According to Sumitomo Pharma 's latest financial reports the company's current earnings (TTM) are -$0.97 B. In 2022 the company made an earning of $0.41 B a decrease over its 2021 earnings that were of $0.52 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.97 B | -335.19% |
2022 | $0.41 B | -22.37% |
2021 | $0.52 B | -38.75% |
2020 | $0.86 B | -2.03% |
2019 | $0.88 B | 8.1% |
2018 | $0.81 B | 20.91% |
2017 | $0.67 B | 55.41% |
2016 | $0.43 B | 40.35% |
2015 | $0.30 B | -11.52% |
2014 | $0.34 B | 63.47% |
2013 | $0.21 B | -33.8% |
2012 | $0.32 B | 15.7% |
2011 | $0.27 B | -6.02% |
2010 | $0.29 B | -22.49% |
2009 | $0.38 B |